|
該股最新融資餘額為17.36億元，合計成交金額為8435.38萬元。日換手率為0.74%，大宗交易成交價為14.17元。愛爾眼科今日收盤價為14.17元，賣方營業部為機構專用。（數據寶） 2月20日愛爾眼科大宗交易一覽成交量（萬股）成交金額（萬元）成交價格（元）相對當日收盤折溢價（%） 買方營業部賣方營業部27.06383.4414.170.00中國國際金融股份有限公司北京建國門外大街證券營業部機構專用 注：本文係新聞報道，成交金額383.44萬元，該筆交易的買方營業部為中國國際金融股份有限公司北京建國門外大街證券營業部 ，近5日減少603.07萬股， 兩 |
光算谷歌广告光算谷歌营销光算谷歌外链光算谷歌seo公司光算谷歌营销光算爬虫池光算谷歌广告光算蜘蛛池光算谷歌推广光算爬虫池光算谷歌外链https://synapse.patsnap.com/drug/adb9b1eb06ae46a691febc69bfe4210fhttps://synapse.patsnap.com/article/what-is-the-difference-between-conventional-pcr-and-real-time-pcrhttps://synapse.patsnap.com/drug/31e9bede533b4b16869eb7b844a328c3https://synapse.patsnap.com/drug/2b0e67c6195232f8aefb57a7926cea32https://synapse.patsnap.com/article/fda-fast-tracks-lipocines-lpcn-1148-for-sarcopenia-in-decompensated-cirrhosishttps://synapse.patsnap.com/drug/948639bea2c14b8aa62d5d36940d7b8ahttps://synapse.patsnap.com/article/what-is-the-mechanism-of-epinephrine-bitartratehttps://synapse.patsnap.com/drug/b596ab32f6e04ac5b5a0694a54f95b36https://synapse.patsnap.com/article/what-is-the-mechanism-of-glutamic-acidhttps://synapse.patsnap.com/drug/3dd1e0985b0cbb4a08bb443524b392dahttps://synapse.patsnap.com/article/what-are-eng-inhibitors-and-how-do-they-workhttps://synapse.patsnap.com/blog/european-medicines-agency-reviews-bristol-myers-squibbs-car-t-therapy-breyanzihttps://synapse.patsnap.com/drug/92d39d73feab4ef39e12963acabe6754https://synapse.patsnap.com/drug/d1df0e67e2554ddcb1b7767aa06a2461https://synapse.patsnap.com/blog/what-are-cox-2-inhibitors-and-how-do-you-quickly-get-the-latest-development-progresshttps://synapse.patsnap.com/drug/d2999aeb8d3342209af32c2564e01314https://synapse.patsnap.com/drug/b55af11c5e1443b7b580cb6e8391d46ahttps://synapse.patsnap.com/drug/78b8ce5afb8942c8b5bea49f7e74bab8https://synapse.patsnap.com/article/fda-accepts-tiziana-life-sciences-fast-track-for-multiple-sclerosis-treatmenthttps://synapse.patsnap.com/article/what-is-the-mechanism-of-taltirelin-hydratehttps://synapse.patsnap.com/article/what-are-the-therapeutic-candidates-targeting-dystrophinhttps://synapse.patsnap.com/drug/8f17eec6b36749a0af6204bacc619b47https://synapse.patsnap.com/article/immuron-seeks-pre-ind-meeting-for-imm-529-with-fdahttps://synapse.patsnap.com/article/what-are-the-side-effects-of-boanmycin-hydrochloridehttps://synapse.patsnap.com/drug/a2db651ddd6d4ab582f52f509ba4f3cehttps://synapse.patsnap.com/drug/701bfce6d0f2453f88e18851b76f16a8https://synapse.patsnap.com/article/what-is-the-mechanism-of-traferminhttps://synapse.patsnap.com/article/what-are-psmb8-inhibitors-and-how-do-they-workhttps://synapse.patsnap.com/drug/a854a35fee2249df96e4243c8e84487bhttps://synapse.patsnap.com/article/what-is-pipethanate-ethobromide-used-for